Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Dietary Supplement GMPs Stuck In Transition Limbo

This article was originally published in The Tan Sheet

Executive Summary

FDA's proposed rule establishing dietary supplement Good Manufacturing Practices appears to be caught amid the flood of activity surrounding the transition to a new presidential Administration.

You may also be interested in...



GMPs

"CFSAN's goal is to have [dietary supplement good manufacturing practices] published as a proposed rule by the end of the year," CFSAN Division of Compliance & Enforcement Director John Foret reports at Supply Side East conference May 9, conceding some factors are "beyond our control." Supplement GMPs again are under OMB review after being tied up with change of administrations earlier this year (1"The Tan Sheet" Jan. 29, p. 3)

GMPs

"CFSAN's goal is to have [dietary supplement good manufacturing practices] published as a proposed rule by the end of the year," CFSAN Division of Compliance & Enforcement Director John Foret reports at Supply Side East conference May 9, conceding some factors are "beyond our control." Supplement GMPs again are under OMB review after being tied up with change of administrations earlier this year (1"The Tan Sheet" Jan. 29, p. 3)

GMPs

"CFSAN's goal is to have [dietary supplement good manufacturing practices] published as a proposed rule by the end of the year," CFSAN Division of Compliance & Enforcement Director John Foret reports at Supply Side East conference May 9, conceding some factors are "beyond our control." Supplement GMPs again are under OMB review after being tied up with change of administrations earlier this year (1"The Tan Sheet" Jan. 29, p. 3)

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS092120

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel